Evans D Gareth, Oudit Deemesh, Smith Miriam J, Rutkowski David, Allan Ernest, Newman William G, Lear John T
Division of Evolution and Genomic Science, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.
Manchester Centre for Genomic Medicine, St Mary's Hospital, Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.
J Med Genet. 2017 Aug;54(8):530-536. doi: 10.1136/jmedgenet-2017-104669. Epub 2017 Jun 8.
Gorlin syndrome (GS) is an autosomal dominant syndrome characterised by multiple basal cell carcinomas (BCCs) and an increased risk of jaw cysts and early childhood medulloblastoma. Heterozygous germline variants in and encoding components of the Sonic hedgehog pathway explain the majority of cases. Here, we aimed to delineate genotype-phenotype correlations in GS.
We assessed genetic and phenotypic data for 182 individuals meeting the diagnostic criteria for GS (median age: 47.1; IQR: 31.1-61.1). A total of 126 patients had a heterozygous pathogenic variant, 9 had pathogenic variants and 46 had no identified mutation.
Patients with variants were more likely to be diagnosed earlier (p=0.02), have jaw cysts (p=0.002) and have bifid ribs (p=0.003) or any skeletal abnormality (p=0.003) than patients with no identified mutation. Patients with a missense variant in were diagnosed later (p=0.03) and were less likely to develop at least 10 BCCs and jaw cysts than those with other pathogenic variants (p=0.03). Patients with pathogenic variants were significantly more likely than those with pathogenic variants to develop a medulloblastoma (p=0.009), a meningioma (p=0.02) or an ovarian fibroma (p=0.015), but were less likely to develop a jaw cyst (p=0.0004).
We propose that the clinical heterogeneity of GS can in part be explained by the underlying or variant.
戈林综合征(GS)是一种常染色体显性遗传病,其特征为多发性基底细胞癌(BCC)、颌骨囊肿风险增加以及儿童早期髓母细胞瘤。音猬因子信号通路中编码成分的和基因的杂合种系变异解释了大多数病例。在此,我们旨在描述GS的基因型-表型相关性。
我们评估了182名符合GS诊断标准个体的遗传和表型数据(中位年龄:47.1岁;四分位距:31.1 - 61.1岁)。共有126例患者存在杂合致病性变异,9例有致病性变异,46例未发现突变。
与未发现突变的患者相比,有变异的患者更易较早确诊(p = 0.02),出现颌骨囊肿(p = 0.002),有肋骨分叉(p = 0.003)或任何骨骼异常(p = 0.003)。基因存在错义变异的患者确诊较晚(p = 0.03),与其他致病性变异患者相比,发生至少10个基底细胞癌和颌骨囊肿的可能性更小(p = 0.03)。与有致病性变异的患者相比,有致病性变异的患者发生髓母细胞瘤(p = 0.009)、脑膜瘤(p = 0.02)或卵巢纤维瘤(p = 0.015)的可能性显著更高,但发生颌骨囊肿的可能性更小(p = 0.0004)。
我们认为GS的临床异质性部分可由潜在的或变异来解释。